https://www.pharmaglobenewswire.com/knee-osteoarthritis-market-insights-epidemiology-and-market-forecast-2034/Pharma Globenewswireen2026-04-17T12:48:17+01:00Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast 2034 https://www.pharmaglobenewswire.com/sarcopenia-market-to-grow-from-usd-2276-million-in-2025-to-usd-5626-million-in-2034-delveinsight/Pharma Globenewswireen2026-04-17T12:29:53+01:00Sarcopenia Market to Grow from USD 2,276 Million in 2025 to USD 5,626 Million in 2034 | DelveInsight https://www.pharmaglobenewswire.com/non-postoperative-acute-pain-market-size-valued-at-usd-3600-million-in-2023-delveinsight/Pharma Globenewswireen2026-04-17T12:01:07+01:00Non-postoperative Acute Pain Market Size Valued at USD 3,600 Million in 2023 | DelveInsight https://www.pharmaglobenewswire.com/traumatic-brain-injury-market-projected-to-reach-usd-30-billion-in-2024-growing-at-10-9-cagr-through-2034/Pharma Globenewswireen2026-04-17T11:36:26+01:00Traumatic Brain Injury Market Projected to Reach USD 30 Billion in 2024, Growing at 10.9% CAGR Through 2034 https://www.pharmaglobenewswire.com/systemic-sclerosis-market-projected-to-reach-usd-2660-million-by-2034/Pharma Globenewswireen2026-04-17T10:58:17+01:00Systemic Sclerosis Market Projected to Reach ~USD 2,660 Million by 2034 https://www.pharmaglobenewswire.com/igg4-related-disease-market-set-to-surge-at-34-60-cagr-reaching-new-heights-by-2034-driven-by-emerging-therapies-and-rising-disease-awareness-globally/Pharma Globenewswireen2026-04-17T10:06:52+01:00IgG4-Related Disease Market Set to Surge at 34.60% CAGR, Reaching New Heights by 2034 Driven by Emerging Therapies and Rising Disease Awareness Globally https://www.pharmaglobenewswire.com/inflammatory-myositis-market-set-for-remarkable-growth-projected-cagr-of-11-7-through-2034-driven-by-emerging-therapies-and-rising-patient-demand-across-seven-major-markets/Pharma Globenewswireen2026-04-16T06:50:25+01:00Inflammatory Myositis Market Set for Remarkable Growth: Projected CAGR of 11.7% Through 2034 Driven by Emerging Therapies and Rising Patient Demand Across Seven Major Markets https://www.pharmaglobenewswire.com/chronic-spontaneous-urticaria-market-set-to-surpass-usd-2000-million-by-2025-driven-by-emerging-biologics-rising-disease-awareness-and-expanding-global-treatment-access/Pharma Globenewswireen2026-04-16T06:49:24+01:00Chronic Spontaneous Urticaria Market Set to Surpass USD 2000 Million by 2025, Driven by Emerging Biologics, Rising Disease Awareness, and Expanding Global Treatment Access